How is a dominant-negative mutation different from a loss-of-function mutation?

A simple loss-of-function variant just removes that allele's activity; a dominant-negative variant makes a product that actively interferes with the normal allele's product, so the heterozygous effect is greater than losing one allele alone.

Why are proteins that work as complexes more affected?

If subunits assemble together, a single mutant subunit can be built into the complex and spoil it, so even a 50:50 mix of normal and mutant subunits leaves few fully functional complexes.

Dominant-Negative Mutations

A dominant-negative mutation produces an altered gene product that interferes with the function of the normal product made by the other allele, so that having one mutant copy disrupts the cell even though a normal copy is present. It is one of the principal reasons a loss-of-quality variant can behave dominantly rather than recessively.

Definition

A dominant-negative mutation is a variant whose product antagonises or inactivates the product of the normal allele, producing a phenotype in the heterozygote that is more severe than the simple loss of one allele's function.

Scope

The entry explains the mechanism by which a defective product 'poisons' the activity of the wild-type product, the molecular settings in which this occurs (notably multimeric proteins), and how the dominant-negative effect differs from simple loss of function and from haploinsufficiency. It is a conceptual entry within single-gene disorders and is not clinical guidance.

Core questions

How can a single mutant allele disrupt function when a normal allele is still present?
Why are multimeric proteins especially prone to dominant-negative effects?
How does a dominant-negative effect differ from haploinsufficiency?

Key concepts

Poison-protein effect
Multimeric (oligomeric) protein complexes
Wild-type allele interference
Antimorph (Muller's mutation classes)
Contrast with haploinsufficiency

Key theories

Dominant-negative (antimorphic) inactivation: Herskowitz proposed that a mutant subunit incorporated into a complex with normal subunits can disable the assembly, so that a single mutant allele inactivates the gene's function despite the presence of a wild-type allele.
Molecular basis of dominance: Wilkie organised dominant disease mechanisms into reduced gene dosage (haploinsufficiency), dominant-negative interference, and gain of function, providing a framework for predicting when a loss-of-quality allele acts dominantly.

Mechanisms

When a protein assembles into a complex of several subunits, a mutant subunit that retains the ability to join the complex but cannot perform the function can incorporate alongside normal subunits and inactivate the assembled unit. Herskowitz described this as functional inactivation by a dominant-negative allele and noted its usefulness as an experimental tool as well as a disease mechanism. Wilkie placed it among the molecular bases of dominance, distinguishing it from haploinsufficiency (where halving the normal product is itself insufficient) and from gain of function. In Muller's classical terminology such alleles are antimorphic, acting against the normal allele's product.

Clinical relevance

Recognising a dominant-negative mechanism helps explain why some heterozygous mutations cause disease while complete loss of one allele of the same gene may not, and it informs how variant effects are interpreted in research and curation. This is descriptive background on disease mechanism and is not a basis for diagnosis or treatment of any individual.

History

Hermann Muller's 1932 classification of mutations introduced the antimorph as an allele acting against the wild type, anticipating the dominant-negative idea. Herskowitz crystallised the concept in 1987, describing how dominant-negative alleles inactivate gene function and could be exploited experimentally, and Wilkie's 1994 review then integrated it into a general account of why mutations are dominant or recessive.

Key figures

Ira Herskowitz
Andrew Wilkie
Hermann J. Muller

Seminal works

herskowitz-1987
wilkie-1994

Frequently asked questions

How is a dominant-negative mutation different from a loss-of-function mutation?: A simple loss-of-function variant just removes that allele's activity; a dominant-negative variant makes a product that actively interferes with the normal allele's product, so the heterozygous effect is greater than losing one allele alone.
Why are proteins that work as complexes more affected?: If subunits assemble together, a single mutant subunit can be built into the complex and spoil it, so even a 50:50 mix of normal and mutant subunits leaves few fully functional complexes.